Injective

Injective is our favorite altcoin, and we hold a strong conviction in its long-term potential. While we acknowledge that we are in the late stages of the bull market, we believe Injective has the potential for one more strong upward move before entering a broader market correction.

Our target for the cycle top is around $70, which appears both logical and achievable based on the current wave structure and technical indicators. In the short term, Injective remains in a minor corrective phase, which we expect to conclude within the next few weeks, paving the way for a significant bullish breakout.


Detailed Observations


Projected Targets


Key Points to Monitor


Conclusion

From our perspective, Injective remains exceptionally well-positioned for one final strong upward move in this bull cycle. While short-term corrections persist, they appear to be part of a healthy consolidation phase before the next leg higher. Our $70 target remains intact, provided support levels hold, and bullish momentum resumes as expected.

We remain highly confident in Injective’s potential and look forward to significant gains as the market resolves this corrective phase. Let us know if further refinements or insights are needed!